HIMS

Hims & Hers Health, Inc.

28.06 USD

Last updated Oct 9, 04:13 UTC

Yesterday HIGH

$29.92

Yesterday LOW

$28.75

52w HIGH

$65.3

52w LOW

$13.74

EPS

-0.37

PE

-75.82

Next Earnings

Nov 2, 2026

Overview News Unusual Options Flow Insider Transactions Government Trades Fundamentals

Hims & Hers Health, Inc. stock is up 0.56% since 30 days ago. The next earnings date is Nov 2, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 28.57% of the previous 7 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 5 CALLs, 5 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

08 Oct 15:05	15 Jan, 2027	28.00	CALL	100	446
08 Oct 15:11	16 Oct, 2026	27.50	PUT	1000	403
08 Oct 15:40	17 Dec, 2027	25.00	PUT	40	1754
08 Oct 16:09	15 Jan, 2027	25.00	CALL	50	3267
08 Oct 16:11	15 Jan, 2027	25.00	CALL	44	3267
08 Oct 16:19	21 May, 2027	30.00	CALL	50	199
08 Oct 16:26	16 Oct, 2026	28.00	PUT	207	5777
08 Oct 16:58	16 Oct, 2026	27.50	CALL	366	107
08 Oct 18:48	16 Oct, 2026	45.00	PUT	29	45
08 Oct 19:26	15 Jan, 2027	40.00	PUT	30	5218

Advanced Data Unlock

Benzinga Newsdesk

Tue Aug 11, 2026

Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $26.
Benzinga Newsdesk

Tue Aug 11, 2026

B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $30 to $32.
Benzinga Newsdesk

Tue Aug 11, 2026

TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.
Benzinga Newsdesk

Tue Aug 11, 2026

Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28

Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and raises the price target from $21 to $28.
Priya Nigam

Tue Aug 11, 2026

Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst

HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.
Kaustubh Bagalkote

Tue Aug 11, 2026

Why Is Hims & Hers Health Stock Falling Tuesday?

Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.
Avi Kapoor

Tue Aug 11, 2026

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.
Benzinga Newsdesk

Tue Aug 11, 2026

Hims & Hers Health shares are trading lower after the company reported mixed Q2 financial results.
Benzinga Newsdesk

Tue Aug 11, 2026

Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42

Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target from $35 to $42.
Shivdeep Dhaliwal

Tue Aug 11, 2026

Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today

RKLB, HIMS, ASTS, ACHR, PLUG were among the stocks seen trending on Monday, Aug. 10, 2026.

JP Morgan

Fri Sep 11, 14:26

hold

initial

Advanced Data Unlock

Oluyemi Okupe, Chief Financial Officer

Thu Oct 1, 2026

HIMS Recent Insider Trades and Stock Chart

2,000 shares sold
Soleil Boughton, Chief Legal Officer

Wed Sep 30, 2026

HIMS Recent Insider Trades and Stock Chart

3,461 shares sold
Oluyemi Okupe, Chief Financial Officer

Tue Sep 22, 2026

HIMS Recent Insider Trades and Stock Chart

29,277 shares sold
Oluyemi Okupe, Chief Financial Officer

Thu Sep 17, 2026

HIMS Recent Insider Trades and Stock Chart

12,313 shares sold
Soleil Boughton, Chief Legal Officer

Wed Sep 16, 2026

HIMS Recent Insider Trades and Stock Chart

6,236 shares sold
Michael Chi, Chief Operating Officer

Tue Sep 15, 2026

HIMS Recent Insider Trades and Stock Chart

14,027 shares sold
Mohamed Elshenawy, CTO

Tue Sep 15, 2026

HIMS Recent Insider Trades and Stock Chart

7,954 shares sold